B. Braun Offering Plenamine™ 15% Amino Acids Injection in Flexible Containers
BETHLEHEM, Pa., March 28, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in parenteral nutrition, now offers Plenamine 15% Amino Acids Injection in 1-liter Pharmacy Bulk Package (PBP) flexible containers. With a port designed for easy spiking and linear and 2D barcodings, Plenamine 15% in a flexible container also has an oxygen sensor to detect product integrity. The flexible container for Plenamine 15% is not made with natural rubber latex, DEHP, or PVC.
Plenamine 15% amino acids for injection is part of B. Braun’s Parenteral Nutrition Program (PN360), a complete therapeutic approach to nutrition through a comprehensive offering of products, education, training, and consultative services. “PN360 is a collaborative program with pharmacists, physicians, nurses, and dietitians to tailor nutritional therapy for the most critical hospital patients, and is designed to help reduce medical errors, infections, and re-admissions,” said Rob Albert, Senior Vice President and Chief Marketing Officer at B. Braun.
Plenamine 15% Amino Acids Injection is a sterile, clear, nonpyrogenic solution of essential and nonessential amino acids for intravenous infusion in parenteral nutrition following appropriate dilution. Plenamine 15% is not for direct infusion. It is a sterile dosage form, which contains several single doses for use in a pharmacy admixture program in the preparation of intravenous parenteral fluids.
For additional information, please see the Full Prescribing Information.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and compounding, ostomy and wound care, and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Allison Longenhagen
B. Braun Medical Inc.
Upcoming Life Sciences Events
- October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction